Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 479 All time
- Disclosed funding
- $19.6B 405 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| Q QuberTechCompany profile Develops sustainable natural rubber from engineered dandelions using controlled-environment biotech Develops sustainable natural rubber from engineered dandelions using controlled-environment biotech | £3.4M | Seed | Biotech | United Kingdom | Investors | |
| BB Blank BioCompany profile Trains RNA foundation models on tumor transcriptomes to improve patient-level prediction in oncology Trains RNA foundation models on tumor transcriptomes to improve patient-level prediction in oncology | $7.2M | Seed | Biotech | United States | Investors | |
| FB Forlong BiotechnologyCompany profile Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer | $17.5M | Pre-Series BUndisclosed | Biotech | China | Investors | |
| PB ProEncia BiotechnologyCompany profile Develops non-invasive periodontal care products for patients with periodontal disease Develops non-invasive periodontal care products for patients with periodontal disease | Undisclosed | Pre-SeedPre-seed | Biotech | United States | Investors Undisclosed | |
| CH Century HealthCompany profile Automates curation and enrichment of real-world clinical data for pharmaceutical and life sciences research Automates curation and enrichment of real-world clinical data for pharmaceutical and life sciences research | $5M | Seed | Biotech, Healthtech | United States | Investors | |
| AB Accro BioscienceCompany profile Clinical-stage medicines targeting inflammation and regulated cell-death pathways in immune-mediated disease. Clinical-stage medicines targeting inflammation and regulated cell-death pathways in immune-mediated disease. | $50M | Series CSeries C+ | Biotech | United States | Investors | |
| FT Full-Life TechnologiesCompany profile Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing | $150M | Series D+DebtUndisclosed | Biotech | China | Investors | |
| VT Violet TherapeuticsCompany profile Develops first-in-class small molecule therapies for neurodegenerative disease via glial cell signaling platform Develops first-in-class small molecule therapies for neurodegenerative disease via glial cell signaling platform | $4.8M | Seed+Seed | Biotech | United States | Investors | |
| A AlcolaseCompany profile Alcolase is developing a liposomal enzyme system intended to break down alcohol in the stomach before absorption. Alcolase is developing a liposomal enzyme system intended to break down alcohol in the stomach before absorption. | €1.5M | Undisclosed | Biotech | Denmark | Investors | |
| WB Wonderlab BioCompany profile Makes off-the-shelf iPSC-derived cell therapies using HLA-matched super donors for broad patient access Makes off-the-shelf iPSC-derived cell therapies using HLA-matched super donors for broad patient access | Undisclosed | StrategicUndisclosed | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →